Free Trial
→ Your Bank Account Is No Longer Safe (From Priority Gold) (Ad)tc pixel Free ESLOY Stock Alerts

EssilorLuxottica (ESLOY) Stock Forecast & Price Target

EssilorLuxottica logo
$161.89 +0.51 (+0.32%)
As of 01:11 PM Eastern
Compare

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold
Based on 3 Analyst Ratings
Sell
0
Hold
2
Buy
1

Based on 3 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 2 have given a hold rating, and 1 has given a buy rating for ESLOY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
9/22/24 to 9/22/25		1 Month Ago
8/23/24 to 8/23/25		3 Months Ago
6/24/24 to 6/24/25		1 Year Ago
9/23/23 to 9/22/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingHoldHoldHoldHold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Stock vs. The Competition

TypeEssilorLuxotticaMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.78
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted UpsideN/A14,947.87% Upside11.30% Upside
News Sentiment Rating
Neutral News

See Recent ESLOY News
Positive News
Positive News
Export to Excel
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
9/10/2025Zacks Research
0 of 5 stars		 UpgradeStrong Sell ➝ Hold
9/9/2025Barclays
3 of 5 stars		 Initiated CoverageOverweight
1/29/2025Royal Bank Of Canada
3 of 5 stars
P. Dadhania
Not Rated
UpgradeHold ➝ Moderate Buy
12/3/2024UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
S. Tibaldi
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:33 PM ET.


Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, September 21, 2025. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The current stock price is around $154.68, which may present a buying opportunity for investors looking for growth in the eyewear and optical industry.
  • EssilorLuxottica Société anonyme has recently seen a significant increase in trading volume, indicating heightened investor interest and potential momentum in the stock.
  • Analysts have upgraded the stock rating from "strong sell" to "hold," suggesting a more favorable outlook and potential for price appreciation.
  • The company operates a diverse range of well-known brands, including Ray-Ban and Oakley, which can drive consistent revenue through strong consumer demand.
  • With a low debt-to-equity ratio, the company is in a strong financial position, which can provide stability and reduce risk for investors.

EssilorLuxottica
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • The stock has experienced fluctuations, with a recent decline from a closing price of $156.30, which may raise concerns about short-term volatility.
  • Despite recent upgrades, the consensus rating remains a "hold," indicating that there may not be strong bullish sentiment among analysts at this time.
  • The company's quick ratio of 0.65 suggests that it may face challenges in meeting short-term liabilities, which could impact liquidity.
  • In a competitive market, the company faces pressure from both established brands and new entrants, which could affect market share and profitability.
  • Recent changes in consumer behavior and economic conditions may pose risks to sales, particularly in the luxury eyewear segment.

ESLOY Forecast - Frequently Asked Questions

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ESLOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESLOY, but not buy additional shares or sell existing shares.

According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, EssilorLuxottica's stock had 1 upgrade by analysts.

EssilorLuxottica has been rated by research analysts at Barclays, and Zacks Research in the past 90 days.

Analysts like EssilorLuxottica less than other "medical" companies. The consensus rating for EssilorLuxottica is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ESLOY compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (OTCMKTS:ESLOY) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Prepare for the “Mar-a-Lago Accord” Money Shock
Why Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...
Stansberry Research | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
Trump’s new nightmare begins
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
The next AI Hype Spike is days away — don’t miss it
On this date, AI could trigger the kind of predictable surge that's already paid out 61%… 158%… and even 382% ...
Brownstone Research | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel